ASPIRE BIOPHARMA HOLDINGS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ASPIRE BIOPHARMA HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $9.00M.
- ASPIRE BIOPHARMA HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $8.95M.
- ASPIRE BIOPHARMA HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $28.56K.
- ASPIRE BIOPHARMA HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $229.08K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $9.00M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $8.95M 10-Q · filed 2026-08-13 | |
| 2024-06-30 | $28.56K 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $229.08K 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |